drugset / Trial / NCT01424163

Dexpramipexole Japanese PK Study

NCT01424163

Phase 1 Completed 57 enrolled Knopp Biosciences Biogen · collab
Non-randomizedCrossoverOpen-labelBasic science

Summary

This is a single and multiple dose, open-label study to evaluate the pharmacokinetics (PK), safety, and tolerability of dexpramipexole administered orally to adult Japanese and Caucasian healthy subjects.

Timeline

Start
2011-08
Primary completion
2012-02
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexpramipexole Small molecule Oral